Tema Neuroscience and Mental Health ETF
MNTL

$27.33

1.52%

Market Cap: $12M

0

Funds holding %

of 6,710 funds

–

Analysts bullish %

Fund manager confidence

Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)

100% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 1

33% more funds holding

Funds holding: 3 [Q1] → 4 (+1) [Q2]

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

1.42% less ownership

Funds ownership: 8.66% [Q1] → 7.25% (-1.42%) [Q2]

18% less capital invested

Capital invested by funds: $996K [Q1] → $820K (-$176K) [Q2]

See Fund Rankings

Research analyst outlook

We haven’t received any recent analyst ratings for MNTL.

See Analyst Rankings

Financial journalist opinion

MNTL ETF: Neuroscience & Mental Health ETF

Tema ETFs recently launched the neuroscience and mental health ETF. MNTL ETF is designed to invest in companies at the forefront of combating neurological diseases and psychiatric disorders.

MNTL ETF: Neuroscience & Mental Health ETF

This Week in ETFs: Closures Outnumber New ETFs

Although 14 new ETFs debuted in the U.S. this past week, closure announcements came in even stronger, largely due to Global X pruning its lineup. Launches during the week included funds from BondBloxx, WisdomTree, Innovator, JPMorgan, and Range ETFs.

This Week in ETFs: Closures Outnumber New ETFs

See News Rankings